Meeting
2018 ASCO Annual Meeting
A longitudinal assessment to evaluate the impact of higher body mass index on cancer-related fatigue in breast cancer patients receiving chemotherapy.
Authors
Julia Ellen Inglis
University of Rochester Medical Center, Rochester, NY
Julia Ellen Inglis , Michelle Christine Janelsins , Eva Culakova , Javier Bautista , Karen Michelle Mustian , Po-Ju Lin , Ian Kleckner , Luke Joseph Peppone
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Late and Long-Term Effects
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10061)
DOI
10.1200/JCO.2018.36.15_suppl.10061
Abstract #
10061
Poster Bd #
49
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Cancer-related fatigue in breast cancer survivors: A longitudinal analysis compared to matched controls.
First Author: AnnaLynn Williams
Poster
2013 ASCO Annual Meeting
Effect of capping chemotherapy dose on chemotherapy effect in morbidly obese women with breast cancer.
First Author: David James Porter
Poster
2011 ASCO Annual Meeting
Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials.
First Author: O. Gluz
Poster
2011 ASCO Annual Meeting
Overall survival effect of lower chemotherapy dosing in extremely obese (BMI ≥ 35) patients with breast cancer based on adjusted BSA.
First Author: P. Sharma